투석적절도의 효율성
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Su-Hyun | - |
dc.contributor.author | Kim, Yong Kyun | - |
dc.contributor.author | Yang, Chul Woo | - |
dc.date.available | 2019-03-09T01:42:14Z | - |
dc.date.issued | 2013-07 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.issn | 2093-5951 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14519 | - |
dc.description.abstract | Adequate dialysis is essential for improving dialysis therapies and reducing all-cause mortality in end-stage renal disease (ESRD) patients. Efficient removal of the uremic toxins in the blood remains the fundamental role of dialysis therapies. Therefore, urea clearance as assessed by urea kinetic modeling (Kt/V-urea) is a surrogate marker for dialysis adequacy in ESRD patients undergoing dialysis, and the NKF-DOQI recommends a Kt/V-urea of no less than 1.2. The current status of dialysis adequacy in Korea has not been fully investigated. Our Clinical Research Center for End Stage Renal Disease revealed that the mean Kt/V-urea in maintenance hemodialysis patients was 1.49 +/- 0.28, and 91.5% of patients satisfied the target level of Kt/V-urea. In addition to Kt/V-urea, clinical parameters such as the volume status, residual renal function, blood pressure, acid-base disorders, anemia, nutrition, inflammation, mineral metabolism, and middle molecule clearance are important for determining adequate dialysis treatment. Further evaluation of clinical parameters is needed to improve dialysis adequacy. | - |
dc.format.extent | 9 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.title | 투석적절도의 효율성 | - |
dc.title.alternative | The efficacy of dialysis adequacy | - |
dc.type | Article | - |
dc.identifier.doi | 10.5124/jkma.2013.56.7.583 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.56, no.7, pp 583 - 591 | - |
dc.identifier.kciid | ART001789094 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000322055000006 | - |
dc.identifier.scopusid | 2-s2.0-84881099757 | - |
dc.citation.endPage | 591 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 583 | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 56 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Dialysis | - |
dc.subject.keywordAuthor | Renal insufficiency | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordAuthor | Uremia | - |
dc.subject.keywordAuthor | 투석 | - |
dc.subject.keywordAuthor | 말기신부전 | - |
dc.subject.keywordAuthor | 생존율 | - |
dc.subject.keywordAuthor | 요독증 | - |
dc.subject.keywordPlus | RESIDUAL RENAL-FUNCTION | - |
dc.subject.keywordPlus | AMBULATORY PERITONEAL-DIALYSIS | - |
dc.subject.keywordPlus | NATIONAL COOPERATIVE DIALYSIS | - |
dc.subject.keywordPlus | HEMODIALYSIS-PATIENTS | - |
dc.subject.keywordPlus | RELATIVE CONTRIBUTION | - |
dc.subject.keywordPlus | PATIENT SURVIVAL | - |
dc.subject.keywordPlus | CLEARANCE | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | (NECOSAD)-2 | - |
dc.subject.keywordPlus | REMOVAL | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.